Research ArticleTheranostics
SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard and Daniela E. Oprea-Lager
Journal of Nuclear Medicine September 2021, 62 (9) 1264-1269; DOI: https://doi.org/10.2967/jnumed.120.260232
Yves J.L. Bodar
1Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
2Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
3Prostate Cancer Network, Noord Holland, The Netherlands; and
Berend P.F. Koene
1Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
Bernard H.E. Jansen
1Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
2Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
3Prostate Cancer Network, Noord Holland, The Netherlands; and
Matthijs C.F. Cysouw
2Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
Dennie Meijer
1Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
2Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
3Prostate Cancer Network, Noord Holland, The Netherlands; and
N. Harry Hendrikse
2Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
4Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands
André N. Vis
1Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
3Prostate Cancer Network, Noord Holland, The Netherlands; and
Ronald Boellaard
2Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
Daniela E. Oprea-Lager
2Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 9
September 1, 2021
SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard, Daniela E. Oprea-Lager
Journal of Nuclear Medicine Sep 2021, 62 (9) 1264-1269; DOI: 10.2967/jnumed.120.260232
SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard, Daniela E. Oprea-Lager
Journal of Nuclear Medicine Sep 2021, 62 (9) 1264-1269; DOI: 10.2967/jnumed.120.260232
Jump to section
Related Articles
Cited By...
- No citing articles found.